Recapitulation of erythropoiesis in congenital dyserythropoietic anaemia type I (CDA-I) identifies defects in differentiation and nucleolar abnormalities

The investigation of inherited disorders of erythropoiesis has elucidated many of the principles underlying the production of normal red blood cells and how this is perturbed in human disease. Congenital Dyserythropoietic Anaemia type 1 (CDA-I) is a rare form of anaemia caused by mutations in two ge...

Full description

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 106; no. 11; pp. 2960 - 2970
Main Authors Scott, Caroline, Downes, Damien J, Brown, Jill M, Beagrie, Robert, Olijnik, Aude-Anais, Gosden, Matthew, Schwessinger, Ron, Fisher, Christopher A, Rose, Anna, Ferguson, David J P, Johnson, Errin, Hill, Quentin A, Okoli, Steven, Renella, Raffaele, Ryan, Kate, Brand, Marjorie, Hughes, Jim, Roy, Noemi B A, Higgs, Douglas R, Babbs, Christian, Buckle, Veronica J
Format Journal Article
LanguageEnglish
Published Italy Fondazione Ferrata Storti 01.11.2021
Ferrata Storti Foundation
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The investigation of inherited disorders of erythropoiesis has elucidated many of the principles underlying the production of normal red blood cells and how this is perturbed in human disease. Congenital Dyserythropoietic Anaemia type 1 (CDA-I) is a rare form of anaemia caused by mutations in two genes of unknown function: CDAN1 and CDIN1 (previously called C15orf41), whilst in some cases, the underlying genetic abnormality is completely unknown. Consequently, the pathways affected in CDA-I remain to be discovered. To enable detailed analysis of this rare disorder we have validated a culture system which recapitulates all of the cardinal haematological features of CDA-I, including the formation of the pathognomonic 'spongy' heterochromatin seen by electron microscopy. Using a variety of cell and molecular biological approaches we discovered that erythroid cells in this condition show a delay during terminal erythroid differentiation, associated with increased proliferation and widespread changes in chromatin accessibility. We also show that the proteins encoded by CDAN1 and CDIN1 are enriched in nucleoli which are structurally and functionally abnormal in CDA-I. Together these findings provide important pointers to the pathways affected in CDA-I which for the first time can now be pursued in the tractable culture system utilised here.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Disclosures
Contributions
No conflicts of interest to disclose.
CS and DJD extracted CD34+ cells from CDA-I patient blood and normal donors respectively; CS, DJD, MG performed the experiments with help from AAO, RB, DJD and RS undertook the ATAC analysis; DJPF and EJ performed the electron microscopy; JMB conducted the immunofluorescence, FISH and EU labeling and analyzed the images; CF and AR conducted the IEF; MB conducted the CyTOF and the data was analyzed by RB, QAH, SO, RR, KR and NR were the clinicians responsible for the care of the of the CDA-I patients; CS, DJD, JH, CB and VJB conceived and designed experiments; DRH provided conceptual advice and clinical oversight; DJD and VJB created the figures; CS, DRH and VJB wrote the paper. All authors reviewed and critically edited the manuscript.
ISSN:0390-6078
1592-8721
DOI:10.3324/haematol.2020.260158